TBA Law Blog

Posted by: Brittany Sims on Jul 5, 2013

U.S. Sen. Lamar Alexander, R-Tennessee, is renewing his push for more stringent oversight of drug compounders, as the fungal meningitis death toll stemming from a Massachusetts-based company rises to 61, the Memphis Business Journal reports. The Pharmaceutical Compounding Quality and Accountability Act, introduced by Alexander and health committee chairman Tom Harkin, D-Iowa, with Sens. Pat Roberts, R-Kansas, and Al Franken, D-Minnestoa, calls on compounding manufacturers to be regulated by the U.S. Food and Drug Administration, while preserving states' roles in regulating traditional pharmacy activity. In stressing urgency, Alexander pointed to a new outbreak stemming from a compounded product from a pharmacy in Newbern, Tenn., which has infected more than 20 people.